Proposed amendments to the articles of association and notice of extraordinary general meeting
Filed with HKEX · Stock code 1779 · · 11 pages · English
Summary by 6ix AI
This filing is a circular regarding proposed amendments to the Articles of Association and includes a notice for an extraordinary general meeting (EGM) of LongBio Pharma (Suzhou) Co., Ltd.. The circular outlines the proposed amendments aimed at reflecting changes in the company's registered share capital and aligning the Articles with applicable laws. It also provides details about the EGM scheduled to discuss and vote on these amendments, including proxy arrangements and voting procedures.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LongBio Pharma (Suzhou) Co., Ltd. on 6ix
Earlier from LongBio Pharma (Suzhou)
- Proposed amendments to the articles of association
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim report
- Altruist Biologics Congratulates Partner LongBio Pharma on the BLA Acceptance of LP-003 by the China NMPA
- Voluntary announcement a phase III clinical trial of LP-003 for the indication of seasonal AR met primary endpoints
Later from LongBio Pharma (Suzhou)
- Notice of extraordinary general meeting
- Form of proxy for use by shareholders at the 2026 EGM (or any adjournment thereof) to be held at 4: 00 p.m. on Friday, October 30, 2026
- Voluntary announcement topline data from the phase ii clinical trial in china of LP-005 for the treatment of pnh
Follow LongBio Pharma (Suzhou) into a list and get an email when it puts out news.
Follow LongBio Pharma (Suzhou)